CJC-1295 with DAC – Research Peptide

CJC-1295 with DAC – Research Peptide
Class: Growth Hormone Releasing Hormone (GHRH) analog  
Form: Lyophilized powder
Purity: ≥ 99% (HPLC verified)
Storage (dry): Room temperature, away from light
Storage (reconstituted): Refrigerate 2–8°C
Solvent compatibility: Bacteriostatic Water (preferred)  
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) that features a specialized modification to extend its half-life. By binding to plasma albumin after administration in research models, the DAC version allows for a more prolonged and sustained release of growth hormone compared to the "w/o DAC" variant. It is a primary tool for scientists studying long-term pituitary stimulation and continuous hormonal signaling.  
Key Research Focus Areas
Extended Half-Life & Plasma Stability: Investigation of the DAC modification’s role in preventing rapid enzymatic degradation and maintaining stable plasma levels.
Continuous Growth Hormone Secretion: Research into the peptide’s ability to promote a steady, elevated baseline of GH release from the pituitary gland.
IGF-1 Pathway Upregulation: Study of the secondary impact on Insulin-like Growth Factor 1 levels and its influence on systemic cellular growth.
Lipid Metabolism & Adipose Research: Analysis of the compound’s efficacy in stimulating lipolysis and regulating metabolic rate over extended durations.
Tissue Repair & Connective Homeostasis: Evaluation of sustained GH elevation on the regenerative capacity of collagen and connective tissues in laboratory settings.
Format Options
 5 mg lyophilized powder
Optional BAC solvent available separately
Important Notice
All products are sold for laboratory research use only. Not for human consumption, injection, or diagnostic use.